With most biologics requiring more than 15 years and $1.2 billion to develop, our efforts to secure capital for small companies includes advocating for government funding of small companies. For example, BIO advocated for the Cures Acceleration Network (CAN) which was authorized under the Patients protection and Affordability Act of 2010. If funded CAN would provide grant funding for public and private entities working on high need cures and help innovative research and development projects become treatments and therapies available for patients.

Cures Acceleration Network: Legislative Text
The Cures Acceleration Network, which would provide funding to public and private entities to bridge the gap between basic research and cures for patients, passed in the recently enacted healthcare reform bill.
Read the legislative text

Cures Acceleration Network: BIO Strongly Supports the CAN Program
Implementation of CAN will help NIH-funded researchers bridge the precarious gap between basic research and the eventual development of new cures and treatments for many of the diseases we face today.
Read BIO’s letter to the Senate Appropriations Committee
Read BIO’s press release

Cures Acceleration Network: Patient Group Letter
The letter, signed by approximately 85 patient groups, requests appropriation for CAN in FY2011.
Read the letter

Technological Innovation Program (TIP): NIST proposes new program support, promote, and accelerate innovation in the United States through high-risk, high-reward research in areas of critical national need.
BIO applauds NIST on implementation of TIP program and urges that personalized medicine be included as an area of "critical national need"
Read about the program

Federal Register Notice of 2010 TIP Competition: NIST issues notice of 2010 TIP competition
NIST includes biomanufacturing as an area of "critical national need" for 2010 TIP competition.
Read the notice

Amendment to Federal Register Notice: NIST issues amendments 2010 TIP competition
NIST clarifies that device development is not a focus of 2010 TIP competition.
Read the amendment